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INTRODUCTION 
In a year plagued by scandal and notable lapses in the human condition,1 even the 
fairytale pursuit of baseball’s home run record ended with a bittersweet note.  As 
with the fabled alchemist who made a deal with the devil in exchange for power and 
worldly experience,2 scores of athletes seemed to cast fate and future to the wind in a 
seductive courtship with performance enhancing drugs.3   
A national icon and red-headed role model for America’s pastime was named 
Time Magazine’s Hero of the Year4, one of the 25 Most Intriguing People of 1998,5 
and the Associated Press (hereinafter AP) Sports Story of the Year.  Nonetheless, 
Mark McGwire’s seventy home runs, which effectively shattered Roger Maris’ 
thirty-seven year old mark, seemed destined to go down in the history books with an 
asterisk6  
While this epic endeavor was hallmarked by his gracious battle against a decades 
old foe in the record books7, the taint of McGwire’s use of a steroid hormone 
supplement8 weighed heavily, like the ancient mariner’s albatross.9  The culprit, 
androstenedione (hereinafter andro), is a legal, dietary “food” supplement to both the 
Food and Drug Administration (FDA) and Major League Baseball10, despite being 
                                                                
1Walter Issacson, How We Made the Choice, TIME, Dec. 28,1998 at 6. References to 1998 
events including Serbian brutality, the Starr Report and the questionable state of public 
education. 
2Faust was a fictional magician and alchemist, inspired by Johann Faust, a 16th century 
German astrologer and magician.  The character, who sold his soul to the devil in exchange for 
power and worldly experience, was the hero of several dramatic works, most notably by 
Christopher Marlowe [English dramatist and poet (1564-1593)] and Johann Wolfgang von 
Goethe [German poet and dramatist (1749-1832)]. 
3John Maher, The Year on Drugs, AUSTIN-AMERICAN STATESMAN, Dec. 29, 1998 at C4. 
Providing a recap, by month and date of more than 140 incidents occurring in organized sport 
and involving the use of generally illegal, performance- enhancing substances. Notable 
highlights include the addition of snowboarders, badminton and snooker players joining the 
ranks of substance abusers. 
4Daniel Okrent, Hero of the Year: A Mac For All Seasons-Mark McGwire’s 70 Home 
Runs Shattered the Most Magical Record in Sports and Gave America a Much Needed Hero, 
TIME, Dec. 28, 1998 at 138. 
5The 25 Most Intriguing People of the Year, PEOPLE MAGAZINE, Dec. 28, 1998 at 50.  
6THE NEW AMERICAN HERITAGE DICTIONARY 80 (1978).  A star-shaped figure (*) used in 
printing to indicate an omission or reference to a footnote.  
7Okrent, supra note 4, at 138. 
8Id.at 142. 
9Literary reference to a constant burden or heavy cross to bear.  From Coleridge’s, Rhyme 
of the Ancient Mariner, the tale of a seafarer who was thought to have sinned by killing an 
albatross, and then had to wear it around his neck as penance. 
10Joel Stein, Mark of Excellence: To Reach the Summit, Mc.Gwire Overcame a Failed 
Marriage, a Crisis of Confidence and a Pain-Racked Body. What Bred the Will to Succeed?, 
TIME, Dec. 28, 1998, at 149.  
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banned by most other sports organizations.11  The defining line between legal and 
illegal substance—between dietary supplement and drug is horribly skewed.  
Accordingly, Part I of this Note will investigate the complexities that exist with 
regard to the classification and regulation of dietary supplements, looking at the 
history leading to the passage of the governing Dietary Health and Supplement Act 
of 1994 (hereinafter DSHEA).  Part II will focus on supplements that consumers may 
use for performance enhancement purposes, and the regulation of sports products.  
Part III will look at the regulatory debate over dietary supplements, the andro 
product example and the interrelationship between drugs and sport.  Part IV will 
briefly comment on the need to establish alternatives for regulating products which 
may affect physiological functions or present substantial health risks.  This note will 
conclude in Part V, analyzing when the FDA should re-examine the distinctions 
between drugs and dietary supplement products and regain the authority to regulate 
supplements to a reasonable level of scientific honesty. 
I.  OVERVIEW OF DIETARY SUPPLEMENT REGULATION 
A.  An Uneven Path: The Winding Road to DSHEA  
1.  Historical Approaches 
Rather tragic circumstances led to the 1938 passage of the Federal Food, Drug 
and Cosmetic Act (hereinafter FDCA), which as amended, regulates food and drug 
today.12 At least seventy-three people died the year before the FDCA’s passage from 
ingesting an “elixir” that was found to contain diethylene glycol, more commonly 
known as antifreeze.13  Prior regulatory measures, including the Pure Food and 
                                                                
11Scott M. Reid, An Issue of Substance: McGwire’s Performance-Enhancing Drug is 
Outlawed by IOC, NCAA and NFL, ORANGE COUNTY REGISTER, Aug. 22, 1998, at D1.  
Summarizing the approach to andro use, by sport. 
ORGANIZATION STATUS PUNISHMENT 
International Amateur Athletic Federation Banned Two-year suspension [1st 
offense]; Lifetime suspension 
[2nd offense] 
International Olympic Committee (IOC) Banned Suspension; Forfeiture of 
Medals 
Major League Baseball Not Covered N/A 
National Basketball League [NBA] Not Covered N/A 
National Collegiate Athletic Association 
[NCAA] 
Banned Suspension 
National Hockey League [NHL] Not Covered N/A 
National Football League [NFL] Banned Suspension 
 
12Pub. L. No. 75-717, 52 Stat. 1040 (1938) (codified as amended at 21 U.S.C. §§ 301-
395(1994)). See David F. Cavers, The Food, Drug and Cosmetic Act of 1938: Its Legislative 
History and Its Substantive Provisions, 6 LAW & CONTEMP. PROBS. 2, 20 (1939).  
13Cavers, supra note 12.  In 1937 ingestion of a product marketed as “Elixir 
Sulfanilimide,” which was found to contain the poisonous liquid form of antifreeze, killed at 
least seventy-three people.  The product’s availability was attributed to the lack of pre-market 
screening of drugs for safety. 
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Drugs Act of 1906 (hereinafter 1906 Act), had failed to require pre-market screening 
of drugs for safety.14 
The resulting Congressional response, the FDCA, required drug manufacturers to 
apply for approval for new drugs and gave the Food and Drug Administration, the 
authority to test products for safe consumption by humans.15  The FDCA supplied 
the FDA with such powerful tools as criminal prosecution, injunction and seizure.16  
As a result the FDA gained the authority to determine which products were safely 
marketable, even absent any evidence of fraud.17 
Although the FDCA altered the FDA’s powers somewhat, the emphasis on fraud 
and contamination has not changed much since the beginning of the century.18  For 
years, the FDA, regulated dietary supplements as foods to ensure their 
wholesomeness and to promote safety by barring false and misleading labels.  
Regulation of the dietary supplement industry has reflected a historic struggle19 
between Congress and the FDA over the checks and balances governing 
classifications under the FDCA.20 
Regulation of food and drugs in this country dates back to 1785, when the first 
food safety regulation was passed in Massachusetts.21  Upon discovering that tainted 
quinine had been supplied to United States troops, the government made its 
inaugural attempt at regulating drug quality.22  The 1906 Act23 was the first federal 
statute to address the adulteration and quality of food and drugs through the interstate 
regulation of domestically manufactured food and drug products.24  Although this act 
                                                                
14Food and Drug Act of 1906, ch. 3915, 34 Stat. 768 (repealed 1938). 
15Pub. L. No. 75-717, 52 Stat. 1040 § 505 (codified as amended at 21 U.S.C.§ 355 
(1994)). 
16Id. 
17Edgar R. Cataxinos, Regulation of Herbal Medications in the United States: Germany 
Provides a Model of Reform, 1995 UTAH L. REV. 561, 564 (1995) (citing PETER TEMIN, 
TAKING YOUR MEDICINE: DRUG REGULATION IN THE UNITED STATES 44 (1980)). Under the 
FDCA, the government has the power to decide which drugs are marketable regardless of 
existence of fraud or misrepresentation.  The 1906 Act protected consumers from fraud and its 
resulting economic harm, but did not serve to protect the public from unsafe drugs–as 
evidenced by the “Elixir Sulfanilimide” tragedy of 1937. 
18PETER B. HUTT & RICHARD A. MERRILL, FOOD AND DRUG LAW: CASES AND MATERIALS 
12 (2d ed. 1991). 
19Eric F. Greenberg, Dietary Supplements Caught in Murky Regulatory Scheme, CHI. 
DAILY L. BULL., Dec. 23, 1998 at 5. 
20Pub. L. No. 75-717, 52 Stat. 1040 (1938), as amended 21 U.S.C. §§ 301 et. seq. (1988). 
21Wallace F. Janssen, America’s First Food and Drug Laws, 30 FOOD DRUG COSM. L.J. 
665, 668-69 (1975).  The “Act against selling unwholesome provisions,” was a comprehensive 
food adulteration law passed by Massachusetts in 1785. 
22Cataxinos, supra note 17, at 562 (citing the Act of June 26, 1848, ch. 70, 9 Stat. 237, and 
Joseph L. Fink & Larry M. Simonsmeier, Laws Governing Pharmacy, in REMINGTON’S 
PHARMACEUTICAL SCIENCES 1890, 1907 (Alfonso R. Gennaro et al. eds., 17th ed. 1985)). 
23Food and Drug Act of 1906, ch. 3915, 34 Stat. 768 (repealed 1938). 
24Cataxinos, supra note 17, at 563. 
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created standards for drugs marketed in interstate commerce, it failed to create 
accountability for false claims about a drug’s therapeutic effects.25  
In 1938, Congress expanded the FDCA “drug” definition to include non-food 
“articles intended to affect the structure or any function of the body of man or other 
animals.”26  Ironically, more than sixty years ago, the very products that the 
legislature sought to regulate were diet aids which were then referred to as anti-fat or 
slenderizing products.27 
Historically, the dietary supplement industry was unable to take advantage of the 
“other than food” distinction because, at the FDA’s urging, courts tended to limit the 
definition of food to that which is ingested for “taste, aroma or nutritive value.”28 In 
1958, dietary supplements began to be regulated as food additives and were 
regulated, in a more stringent manner than conventional foods.29 
The FDA’s conscious desire to promote safe and effective use and proper 
labeling was evidenced in the 1970’s by increased federal regulation of 
supplements.30  Among the safety concerns at this time were those that the FDA had 
regarding high potency vitamins and mineral supplements, and whether their 
potencies should be limited to the minimum levels necessary for nutrition.31  As is 
the case today, there was tremendous industry opposition to the stricter regulations 
and, as a result, the Proxmire Amendment was enacted and added to the FDCA in 
1976.32 
This limitation on the regulation of advertising and labeling prohibited the FDA 
from setting maximum levels of vitamin potencies in food, and from classifying any 
vitamin or a mineral as a drug simply because it exceeded a nutritionally sound 
potency level.33  Congress once again fired a return shot into the dietary supplement 
                                                                
25United States v. Johnson, 221 U.S. 488, 497-98 (1911) (holding that an “effective 
against cancer” claim on a drug label did not violate the 1906 Act). 
2621 U.S.C. § 321(g)(1)(C).  Legislative history suggests that Congress expanded the 
definition in order to include products with physiologic effects unrelated to disease, under the 
FDA’s regulatory purview.  S. REP. NO. 361, 74th Cong., 1st Sess. 3 (1935), reprinted in 3 
LEGISLATIVE HISTORY OF THE FEDERAL FOOD, DRUG AND COSMETIC ACT AND AMENDMENTS 
660. 
27S. Rep. No. 361, 74th Cong., 1st Sess. 3 (1935), reprinted in 3 LEGISLATIVE HISTORY OF 
THE FEDERAL FOOD, DRUG AND COSMETIC ACT AND AMENDMENTS 660. 
28See supra, note 26 and accompanying text.  
29Stephen H. McNamara, Dietary Supplements of Botanicals and Other Substances:  A 
New Era of Regulation, 50 FOOD & DRUG L.J. 341(1995) (discussing food additive regulation). 
30Robin Elizabeth Margolis, Vitamins, Minerals and Herbs: How Should the FDA 
Regulate Dietary Supplements?, 10 HEALTHSPAN, Oct. 1993, at 21, 23 (an explanation of the 
history of dietary supplement regulation.) 
31Margolis, supra note 30, at 23. 
32Id.  See Health Research and Health Services Amendments of 1976, Pub. L. No. 94-278, 
90 Stat. 401, 410-413 (codified at 21 U.S.C. § 350) (date). 
33Pub. L. No. 94-278, 90 Stat. 401, 410-413 (codified at 21 U.S.C. § 350) (date).  See also, 
Margolis supra note 31 at 23.  Noting that in the wake of the Proxmire Amendment, the FDA 
issued minimal regulations for dietary supplements between 1979 and 1993). 
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minefield, enacting the Nutrition Labeling and Education Act of 1990 (hereinafter 
NLEA).34   
2.  The Nutrition Labeling and Education Act of 1990 
The NLEA establishes requirements, including label content for conventional 
foods,35 ingredient listing,36 manufacturer name and address,37 number of servings,38 
and nutrient content claims.39  While food manufacturers may make health claims 
and nutritional support statements, only the health claims are subject to NLEA 
scrutiny, while the balance is not tightly regulated by the FDA.40  Despite making 
claims about effect on body structure or function, dietary supplements can still 
escape classification as “drugs.”41  Health claims, which imply a relationship 
between a food substance in the food and a disease or health-related condition, are 
prohibited by the NLEA unless found by the FDA to have “significantly scientific 
agreement.”42 
Accordingly, absent FDA approval of the claim, health claims cannot appear on 
the label or labeling of food products or dietary supplements.43  In essence, the 
NLEA applies the same standards to dietary supplements as it does to conventional 
foods.44 This increased authority over food labeling exemplifies the dreaded risk 
aversion inherent in the operation of the FDA.45 
While the agency’s historic mission has been one of consumer protection, it is 
often criticized for excessive caution in granting product approval.46  The costs 
                                                                
34Pub. L. No. 101-535, 104 Stat. 2353 (codified as amended at 21 U.S.C. § 343 (1994)). 
35Id. (forbidding, inter alia, false or misleading information and misleading containers). 
3621 C.F.R. § 101.4, .5, .8, .13 (1996) (requiring containers to list a product’s ingredients). 
37§ 101.5. 
38§ 101.8. 
39§ 101.13. 
40Id.  These statements of nutritional support are known as structure/function claims, 
which state non-disease related effects that foods have on the human body. S. REP. NO. 103-
410, at 37 (1994). 
4121 U.S.C. § 321(g)(1)(C) (1994).  Products can still be classified as food not drugs, 
because part (C) of the drug definition excludes foods: “articles (other than food) intended to 
affect the structure or any function of the body of man or other animals.” 
4221 C.F.R. § 101.14(a)(1). Disease or health-related condition includes “damage to an 
organ, part, structure or system of the body such that it does not function properly . . . or a 
state of health leading to such dysfunctioning.”  § 101.14(a)(6). 
43McNamara, supra note 29, at 345.  In the wake of the NLEA, the FDA promulgated 
rules imparting the same standards on dietary supplements as with conventional food. 
44Id. 
45Elizabeth C. Price, Teaching the Elephant to Dance: Privatizing the FDA Review 
Process, 51 FOOD & DRUG L.J. 651, 654 (1996) (discussing the historical factors that have led 
to the FDA’s preference for caution). 
46Id. at 656.  FDA review deficiencies extend beyond drugs, to medical devices and food 
additives as well.  For example, olestra, the innovative fat substitute, received FDA approval 
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associated with satisfying such regulation arguably squelch any incentive there might 
be to bring new and innovative products to market.  Presumably, consumers and 
manufacturers alike are the losers in this regulatory dilemma. 
As a result, politics keep the tug-of-war game going between regulation for 
consumer protection and the need to freely move products to market. In staying true 
to historical course, the FDA’s NLEA-authorized clamp down on dietary 
supplements was followed by yet another attempt to restore equilibrium to the 
regulatory process.47  
3.  Dietary Supplement Act of 1992 
Congress responded to the FDA’s application of conventional food standards to 
dietary supplements, with the Dietary Supplement Act of 1992 (1992 Act),48 which 
restricted the implementation of the NLEA with regard to dietary supplements.49  
The 1992 Act expressly called for the establishment of rules that are specific to 
dietary supplements,50 with the FDA opting to respond with a proposal to revise its 
food labeling regulations to make dietary supplements subject to the same 
requirements as food—a wholesale reiteration of its stance under the NLEA.51 
The FDA’s monopolistic position is exemplified by the agency’s absolute 
unwillingness to consider alternative methods for regulating dietary supplements, as 
Congress seemed to intend with the 1992 Act.52  The lack of tolerance for this “only 
overseer in town” attitude is evident in the well-heeled efforts at reform that 
followed.53 
                                                          
in January 1996, following twenty-one years of agency scrutiny, 100,000 pages of research 
data and development costs in excess of $300,000,000.  See Jennifer Lawrence, What Ever 
Happened to Olestra: How P&G’s Hopes for Food Division’s Future Got Mired in FDA 
Quicksand, ADVERTISING AGE, May 2, 1994, at 16, 17.  Proctor and Gamble filed an 
investigational new drug (IND) application with the FDA in 1975. 
47Pub. L. No. 102-571, 106 Stat. 4491 (1992). 
48Pub. L. No. 102-571, 106 Stat. 4491, 4500-05 (codified as amended at 21 U.S.C. § 343 
(1994)). 
49Id.  § 202 (a)(1), 108 Stat. at 4500.  Establishing a moratorium on the FDA’s application 
of the NLEA.  
50Id. § 202(a)(2)(A) (“[T]he Secretary shall issue . . . proposed regulations that are 
applicable to dietary supplements. . . .”). 
51See Food Labeling: General Requirements for Health Claims in Dietary Supplements, 58 
Fed. Reg. 33,700, 33,700 (1994). 
52Price, supra note 45, at 651.  The FDA’s authority as sole reviewer of the safety and 
efficacy of products requiring pre-market approval gives rise to the monopolistic atmosphere.  
The scope of the agency’s authority is enormous with over $1 trillion in annual revenues 
generated by the products under its purview–or twenty five cents out of every dollar expended 
by American consumers.  See PRESIDENT BILL CLINTON & VICE PRESIDENT AL GORE, 
NATIONAL PERFORMANCE REVIEW: REINVENTING DRUG AND MEDICAL DEVICE REGULATIONS 2 
(1995); See also The FDA Home Page (visited April 14, 1999) 
<http://www.fds.gov/bbs/topics/NEWS/NEW00414.html>.  
53Price, supra note 45, at n.59.  A random review of food and drug company political 
action committee (PAC) contributions during the 1993-1994 contribution cycle, revealed a 
total of $2,548,804 given by 15 drug and 6 food PACs.  Allocated among the 535 
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4.  The Dietary Supplement Health and Education Act of 1994. 
In 1994, Congress sought to reduce such burdens on dietary supplement 
manufacturers by amending the existing law.  Broad, bipartisan support for such 
relief was evident in the absence of a detailed legislative history.54  
The legislature’s loathing for the FDA’s autocratic reign is evidenced in the 
passage of the 1994 Dietary Supplement Health and Education Act (DSHEA),55 
which dealt swiftly with the agency’s apparent unwillingness to effectively address 
the regulation of dietary supplements.  DSHEA gutted the FDA’s authority to 
regulate dietary supplements by exempting claims about the effects of dietary 
supplements on humans56 from the drug provisions of the FDCA.57  Furthermore, the 
DSHEA exempted supplements from food additive definition,58 publication,59 and 
statements of nutritional support,60 while establishing new provisions for claims and 
safety determination.61 
Pursuant to unanimous approval by the House of Representatives on October 6, 
1994 and an identical response from the Senate the next day, The Dietary 
Supplement Health and Education Act of 1994 (DSHEA), was given presidential 
approval on October 25, 1994.62  In its new form, the law statutorily defined dietary 
supplement products as foods63 that are authorized to make claims regarding their 
effect on the structure or function of the human body, regardless of whether they are 
consumed for their “taste, aroma or nutritive value.”64 
Herbs and dietary substances used to supplement the diet are included in the 
DSHEA’s broad definition of “dietary supplement,”65 as are vitamins and minerals.  
Historically, supplements have been marketed absent evidence of nutritional value or 
                                                          
Congressmen and Senators, these 21 PACs alone, averaged $4,764 per member.  See Peter 
Stone, The Demolition Prescription: Industry Leaders and Lawmakers Want to Overhaul the 
Food and Drug Administration, ORLANDO SENTINEL, Mar. 26, 1995, at G1. The Progress and 
Freedom Foundation, a Newt Gingrich backed think-tank, raised over $400,000 from FDA-
regulated entities for “Medical Innovation and Personal Health in the 21st Century”, a project 
aimed at dismantling the FDA and creating a wholly privatized method of product approval. 
54140 Cong. Rec. H11, 173, H11, 179 (daily ed. Oct. 6, 1994). 
55Pub. L. No. 103-417, 108 Stat. 4325 (1994). 
5621 U.S.C. §§ 321(g)(1), 343(r)(6)(A) (1994). 
5721 U.S.C. §§ 301-397 (1994). 
5821 U.S.C. § 321(s) (1994). 
5921 U.S.C. § 343-2 (1994). 
6021 U.S.C. § 343(r)(6) (1994). 
6121 U.S.C. §§ 342(f), §§ 350(b) (1994). 
62Pub. L. No. 103-417, 108 Stat. 4325. 
63Pub. L. No. 103-417, § 3(a)(3), 108 Stat. at 4327 (codified at 21 U.S.C. § 321(ff)(3)). 
64Id. 
6521 U.S.C. § 321 (ff) (1994). 
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known use in food or traditional medicine,66 and the DSHEA does little to provide 
guidance on the expanded new meaning of “dietary.”67  Not surprisingly, the heavily 
deregulated environment fostered by DSHEA is representative of an era in which the 
effects of deregulation are readily questioned.68 
Though supplement manufacturers cannot make prevention and disease treatment 
claims on product labels, the DSHEA does enable them to make statements of 
nutritional support claiming effects on the structure and functions of the body.69  
Similarly, claims of this nature for non-nutritional supplements are no longer 
regarded as drug claims subject to the pre-market approval and controlled testing 
gauntlet of the past.70 
These changes blur the line between food claims and drug claims, as the DSHEA 
limits the FDA’s ability to regulate labeling claims (“the publication exemption”); 
this leaves the door wide open for dietary supplement manufacturers to tout their 
latest and greatest potions as “preventative medicine.”71  As one might expect, 
DSHEA’s deregulatory nature has led to a plethora of new claims being made with 
regard to the miracles of supplement consumption—they help us think better, 
improve the immune system, reduce cholesterol levels and may be all-natural herbal 
replacements for prescription drugs.72 
                                                                
66See FDA Notice of Proposed Rulemaking, 21 C.F.R. ch.1, Regulation of Dietary 
Supplements,58 Fed. Reg. 33,690, 33,697 (1993). 
6721 U.S.C. § 343(r)(6)(A) (1994). 
68In the past decade, deregulation has impacted industry ranging from communications 
and transportation to public utilities.  Results have been mixed.  See generally Christopher 
Clott and Gary S. Wilson, Ocean Shipping Deregulation and Maritime Reports:  Lesson 
Learned From Airline Deregulation, 26 TRANSP. L.J. 205 (1999) (while airline deregulation 
has decreased fares, it has also decreased service to less profitable airports); Michael F. Finn, 
The Public Interest and Bell Entry into the Long-Distance Under Section 271 of the 
Communications Act, 7 COMMLAW CONSPECTUS 173 (1997) (discussing the quid pro quo 
inherent in successful regulation:  the Bell Companies will be allowed into Long-Distance 
service, but must first allow competition in local service); Christine Garcia, A Future of Green 
Power:  Impacts of the Electric Utility Regulation in America, 10 LOY. CONSUMER L. REV. 225 
(1998) (positive effects of deregulation include lower rates for consumers, technological 
advances through competition and increasing accountability for pollution-related damage to 
the environment). 
6921 U.S.C. § 343(r)(6)(A)(1994). 
7021 U.S.C. § 355 (1994).  See Nutrilab v. Schweiker, 713 F.2d 335 (7th Cir. 1983) 
(holding that “starch blockers” constituted “drugs” under the FDCA, since the blockers were 
intended to affect digestion in the people who took them, and that to qualify as a “drug”, an 
article must also “be intended to affect the structure or any function of the body of man or 
other animals”). 
7121 U.S.C. § 343-2 (1994).  The Federal Trade Commission (FTC) may regulate 
advertising, including misleading claims.  The FTC’s authority is different however, from the 
FDA’s, and does not encompass pre-market approval of drug claims.  See 15 U.S.C. §§ 45, 52 
& 55 (1988). 
72Michael Higgins, Hard to Swallow, A.B.A. J., June 1999 at 60 (discussion of the 
regulation of dietary supplements and the marketing hype that may lead manufacturers to the 
courthouse for a number of products and their related health claims including: selenium 
(heart); androstenedione (muscle development); gingerroot (digestion); fo-ti root (kidneys, 
9Published by EngagedScholarship@CSU, 1999
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Where the FDA’s prior ability to require pre-market approval of the safety of 
dietary supplements had previously been narrowed by court decisions,73 the DSHEA 
resulted in full revocation of such power.74  The passage of DSHEA and a failure to 
keep dangerous dietary supplements off the market were viewed as former FDA 
Commissioner Kessler’s “greatest failures.”75  Kessler (an attorney and medical 
doctor) burst onto the regulatory scene in 1991, and as the new Commissioner of the 
U.S. Food and Drug Administration emphatically promised Congress and the 
American public that he “would teach the elephant to dance.”76 
Instead, the mammoth agency appeared to stumble and reel from setbacks.  These 
included legislatively mandated exemptions from strict oversight for questionable 
supplements such as ephedra, which has been linked to several deaths.77  Presumably 
out of frustration, Kessler sounded much like a spurned dance partner in commenting 
at the end of his FDA tenure that “certain problems you aren’t going to solve,” and 
dietary supplements are “one of them.”78 
The deregulatory effect of the Act sent a clear message from Congress to the 
FDA, signaling its intention to end the previously inconsistent approach to regulating 
supplements and to quell the agency’s historic bias towards viewing such substances 
as drugs.79  The enormous influence of the dietary supplement business is reflected in 
the DSHEA, which notes that almost half of all Americans regularly consume some 
form of dietary supplement,80 produced by an industry with annual sales approaching 
$4 billion annually.81 As the findings associated with the DSHEA indicate, a 
                                                          
liver); tribulus terrestris (sexual performance); saw palmetto (prostate); St.John’s Wort 
(mood); gingko biloba, phosphatidyl serine (alertness); echinacea (immune system); lobella 
(lungs); and ephedra (weight loss)). 
73United States v. Oakmont Inv. Co., 937 F.2d 33 (1st Cir. 1993) (holding that 
encapsulated oil, which was “food” in its liquid form, in two inert substances did not render oil 
a “food additive,” presumed to be unsafe absent FDA regulations prescribing conditions 
assuring safe use); United States v. Vipone Ltd. Black Current Oil, 984 F.2d 814 (7th Cir. 
1993) (holding that encapsulated black currant oil (BCO), with a single active ingredient, was 
not a “food additive” and, thus, the processor did not have a burden of proving that BCO was 
generally recognized as safe (“GRAS”), even if BCO was merely a component of BCO dietary 
capsules). 
7421 U.S.C. § 321(s)(6) (1994). 
75Marian Burros, F.D.A. Commissioner is Resigning After 6 Stormy Years in Office, 
N.Y.TIMES, Nov. 26, 1996 at A1.   
76Henry Miller, Anti-Medicine Man: Commissioner David A. Kessler, NAT’L REV., Oct. 9, 
1995, at 48.  
77Burros, supra note 75 at A1.  Congress passed such exemptions under significant 
pressure from the dietary supplement industry. 
78Id. at A18. 
79Greenberg, supra note 19, at 5. 
80Pub. L. No. 103-417, § 2(9), 108 Stat. at 4326. 
81§ 2(12)(C), 108 Stat. at 4326. 
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connection may be made between dietary supplement use, health-care expenditure 
and disease prevention.82 
B.  FDCA’s Regulation of Food and Drugs 
The FDCA regulates the sale of both food and drugs, setting out requirements for 
approval, labeling and dispensation through its statutes and regulations.  As the 
historic treatment of dietary supplements illustrates, drugs are more stringently 
regulated than foods.  
1.  Drugs 
As drugs are more highly regulated than any other type of product,83 a 
manufacturer must first obtain FDA approval before beginning to market or advertise 
a product.84  This hurdle, known as “pre-market approval,” requires substantive 
clinical evidence demonstrating that the drug is both safe and effective for its 
intended use.85 
Habit-forming drugs and those that are potentially harmful or unsafe unless taken 
under supervision, require prescriptions.86  Furthermore, the FDCA prescribes 
precise labeling requirements for drugs, including placement and content.87 
Specific health claims about drugs must also seek approval, conditioned by 
substantial evidence derived from controlled investigations by experts in the field.88  
A manufacturer must also establish a basis in any claim by “sufficient scientific 
agreement,” which may necessitate a large number of experts concurring about the 
meaning of clinical research results.89 
A drug is deemed adulterated and subject to government enforcement actions if it 
contains poisonous or unsanitary ingredients, or if its manufacturing procedure is 
                                                                
82§§ 2(2),(6)(A), 108 Stat. at 4326. 
83Yumiko Ono, States Move to Restrict Fat-Burning Aid Ma Huang, SAN DIEGO UNION-
TRIBUNE, Aug. 11, 1995 at E3. 
8421 U.S.C. § 355(a) (stating that no person shall introduce any new drug into interstate 
commerce unless an application has been approved). 
85§ 355(b)(1) (providing that a manufacturer make “full reports of investigations”). 
86§ 353(b). 
87Id. The information on a label attached to the immediate container of an article must also 
appear on the outside wrapper.  § 321(k).  See § 352(b)-(c) (requiring, inter alia, an accurate 
statement of contents, prominence, warnings if the product is a habit-forming substance, and 
directions for use); § 352(n) (listing guidelines for side effects and contraindications, as well 
as false advertising). 
88§§ 352(a), 355(d) (any such claims would be considered labeling and a drug must be 
approved for all of its labeled uses).  To gain approval as a new drug, and to label and market 
its uses, the manufacturer must present “substantial evidence” that the drug has the claimed 
effect.  § 355(d)(5),(7). 
89Regulation of Dietary Supplements: Hearing Before the Subcommittee on Health and the 
Environment of the Comm. on Energy and Commerce, 103d Cong. 1, 164 (1993) (testimony 
of David A. Kessler, Commissioner of the FDA). 
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contrary to good manufacturing practices.90  Among the enforcement actions that 
drugs are subject to include: search and recall,91 criminal sanctions for prescription 
drug marketing violations,92 and withdrawal of drug application approval.93 
2.  Food 
Food and its subset, food additives, are statutorily defined as: “(1) articles used 
for food or drink for man or other animals, (2) chewing gum, and (3) articles used for 
components of any such article,”94 and  
any substance the intended use of which results or may reasonably be 
expected to result, directly or indirectly in its becoming a component or 
otherwise affecting the characteristics of any food . . . if such substance is 
not generally recognized, among experts qualified by scientific training 
and experience to evaluate its safety, as having been adequately shown 
through scientific procedures . . . to be safe under the conditions of its 
intended use.95 
While food and food additives must meet guidelines concerning adulteration, 
these products are subject to less regulatory scrutiny than drugs, as they do not have 
to meet pre-market approval.96  Food is adulterated if the FDA can establish by a 
preponderance of the evidence that the food is “injurious to health” or contains 
poisonous, unsanitary, or other dangerous ingredients;97 an absence, substitution or 
addition of constituents;98 or unsafe color additives.99  
Food additives will be presumed unsafe absent FDA authorization for their use.100  
While the FDA guidelines for deeming a food additive safe are rigorous,101 
                                                                
9021 U.S.C. § 351(a).  See 21 C.F.R. § 211 (1996).  FDA regulations for “good 
manufacturing practices (GMP’s) cover organization and personnel, building and facilities, 
equipment, control of components and drug product containers and closures, packaging and 
labeling control, holding and distribution, laboratory controls, records and reports, and 
returned and salvaged drug products.  See also 21 U.S.C. § 351(b) (drugs are considered 
adulterated if they differ in strength, quality or purity from the official compendium). 
9121 U.S.C § 334. 
9221 U.S.C. § 333(b). 
9321 U.S.C. § 335(c). 
94
 21 U.S.C. § 321(f) (defining food). 
9521 U.S.C. § 321(s) (defining food additive). 
9621 U.S.C. § 342 (a)-(c) (defining when foods shall be deemed adulterated). 
97§ 342(a). 
98§ 342(b). 
99§ 342(c). 
10021 U.S.C. § 348(a). 
10121 C.F.R. § 170.22 (1996) (explaining that permitted tolerance in humans will not 
exceed one one-hundredth of the maximum tolerable amount in experimental animals). 
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manufacturers may petition the FDA, and request a regulation prescribing safe use of 
product.102 
It should be noted however, particularly when considering sports supplements, 
that an additive is generally considered “safe” if there is sufficient prior usage of 
such additive with no safety problems or if there is a general recognition of its safety 
based on scientific procedures.103 
3.  Dietary Supplements Under the FDCA 
As defined by the DSHEA, a dietary supplement is a “product (other than 
tobacco) intended to supplement the diet.”104  Though specifically excluded from the 
definition of food additives,105 dietary supplement labels under the DSHEA may 
describe ingredients intended to affect the “structure and function in humans,” even 
though the supplements are not drugs.106 
In general, the DSHEA has established relatively lenient standards for health 
claims and claims of nutritional support, with manufacturers only having to 
substantiate that their claims are truthful and not misleading.107  The DSHEA does 
not however, preempt the states from regulating dietary supplements and 
accordingly, inconsistent regulation may occur.108 
And so the tug-of-war between the FDA, Congress and the dietary supplement 
industry continues.  Sports products, such as andro, are illustrative of the ongoing 
conflict and the need for more consistent regulation. 
                                                                
10221 U.S.C. § 348(a). 
10321 C.F.R. § 170.30(a) (the FDA exempts food additives that are generally recognized as 
safe (“GRAS”) from the pre-petition approval requirement). 
104Dietary Supplement Health and Education Act § 3(a), 21 U.S.C. § 321(ff). 
105§ 3(b), 21 U.S.C. § 321(s)(6) (specifying that food additives do not include any 
ingredients described in section 321(ff) or any ingredients for use in dietary supplements). 
10621 U.S.C. § 321(ff)(3)(A).  These products constitute dietary supplements unless the 
Secretary of Health and Human Services issue a regulation, after notice and comment, that the 
article is unlawful.  Provided that the Secretary finds the classification lawful, the products 
may be deemed as such, even though the manufacturer never marketed them as dietary 
supplements.  See also 21 U.S.C. § 321(ff)(3)(B)(ii). 
10721 U.S.C. § 343(r)(6)(B).  Manufacturers are required to place a disclaimer on dietary 
supplements stating that the FDA has not evaluated the validity of the health claim.  See also 
21 U.S.C. § 343(r)(6)(C). 
108See State Official See Flaws in Dietary Supplement Act, FOOD LABELING & NUTRITION 
NEWS, Sept. 28, 1995 at 10 (discussing how the continual modification of dietary supplement 
regulation has led to much uncertainty in the industry). 
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II. SPORTS PRODUCTS AND THEIR CONSUMER USES 
A.  Regulating Sports Products as Dietary Supplements, Conventional Foods, Food 
Additives or Drugs 
Sports products do not fit neatly into a single regulatory classification, given their 
broad range of forms and intended uses.109  These products include items as 
innocuous as sports bars and beverages, which often combine protein or 
carbohydrates with vitamins, minerals, botanicals or biochemicals.110  
Basic products such as beverages are used to replace sugar and fluids lost during 
exercise,111 while bars, powders and pills may be used as snacks and meals and to 
provide necessary nutrients before or after exercise.112  These products can also be 
divided into three basic categories relative to physiological effect: high-protein 
products with amino acids maintain and increase muscle mass;113 high carbohydrate 
products containing sugars, vitamins and minerals provide quick energy and 
improved recovery time;114 and high-calorie products combine increased 
carbohydrate, protein, amino acids and fat for muscle increase and weight gain.115 
These products are popular because they produce significant physiological 
effects, though most have not been proven clinically effective for their claimed 
uses.116  In fact, some ingredients in these products can adversely impact the body 
and present clear danger to consumers.117  The rampant popularity of dietary 
                                                                
109See Bill Brubaker, In NFL, Supplements Complement; With Steroids Banned, Some 
Players Turn to Pills and Powders to Get Ahead, WASH.POST, Jan. 22, 1995 at D 1. 
110Id.  See Fred Weihmuller, Formulating a Sporting Effort, PREPARED FOODS, Feb. 1995, 
at 34 (illustrating the various forms of sports products). 
111See Leigh Pressley, A Powerful Thirst, Think First, Guzzle Later Experts Say, 
GREENSBORO NEWS & RECORD, July 28, 1995 at D1. 
112Weihmuller, supra note 110 at 38 (explaining that athletes rely on the carbohydrates 
found in these products to maintain and enhance athletic performance). 
113Id. at 36, 38 (explaining the three categories of sports products and the function of 
protein). 
114Id. at 39 (discussing the mechanism underlying carbohydrate breakdown during 
exercise). 
115Id. 
116Id. at 44.  An excellent example is chromium piccolinate, a popular ingredient in sports 
products and a required element of carbohydrate metabolism.  Id. While manufacturers claim 
that taking it in increased doses will enhance metabolism, there is no scientific evidence to 
support such a claim.  Id. 
117Mike Fish, Sports Supplements: Big Hype, Little Help:  USOC Tie to Supplier 
Questioned NuSkin’s Image, Marketing Approach Not Exactly Golden, ATLANTA CONST., Dec. 
11, 1994 at E 16 (discussion of the FDA’s increased regulation of sports products in the wake 
of 38 deaths between 1989 and 1992, attributable to L-tryptophan, an amino acid).  Although 
officially banned from the market, L-tryptophan is still found in some sports products.  Id. 
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supplements118 gives rise to the need for resolution of the regulatory conflict and the 
promotion of a much-needed balance between consumer safety and consumer 
freedom. 
Under DSHEA, the regulations governing such products turn on product, rather 
than on function.  Ironically, sports bars and beverages, which are typically safer 
than other supplements, are regulated more stringently based on their classification 
as conventional foods.119 
Powders and pills however, are classified as dietary supplements, and thus 
subject to the more lenient regulatory regime established by the DSHEA.120  It may 
be more desirable to regulate these items, which often contain dangerous amino acids 
and herbal ingredients, as food additives, which would subject them to stricter 
scrutiny.121  
Ultimately, whether a product is classified as a drug, food, food additive or 
dietary supplement, turns on four critical considerations:  product definition, product 
safety, nutritional support claims, and labeling.122 
1.  Product Definition 
For years the FDA has considered dietary supplements to be composed of 
essential nutrients, such as vitamins, minerals and proteins.123  In the past, substances 
                                                                
118See CEO Interview: General Nutrition Cos., Inc.(GNCI), WALL STREET TRANSCRIPT, 
Apr. 11, 1994 (listing categories of dietary supplements and noting that the industry in the 
United States is a $3.7 billion dollar market). 
119See FDA Petitioned to Define Powders, Other Supplements as Supplements, FOOD 
LABELING NEWS, Apr. 21, 1994 at 7.  In 1994, the National Nutritional Foods Association 
petitioned the FDA for regulation of sports bars and drinks as dietary supplements, rather than 
as foods.  The Association argued that if the intended use of the products was to add nutrients 
to the diet, then the foods are not used “conventionally,” and therefore their regulatory 
classification should be determined by use, not by form.  Id. 
120
 See Dietary Supplement Health and Education Act of 1994 § 3(a), 21 U.S.C. § 321(ff) 
(1994) (defining dietary supplements as products containing amino acids and herbs). 
121Ono, supra note 83 at E3 (explaining that many sports products contain herbal 
ingredients that can prove dangerous if not used properly).  For example, ephedrine has been 
used for thousands of years and is an active ingredient in popular drugs, but has side effects 
including high blood pressure and irregular heartbeats.  See Pressley, supra note 112 at D1 
(noting that ephedrine is found in the popular herb ma huang, and that such ingredients, if not 
used correctly, can be harmful).  Id. 
122See 21 U.S.C. §§ 321, 341-343 (1994) (discussion of definitions, health claims, safety 
and labeling). 
123Dietary supplements have been long regarded by the FDA as the type of food intended 
for “special dietary uses.”  The Federal Food, Drug & Cosmetic Act (FDCA), § 403(j) 
provides that a food is “misbranded” and thus illegal unless its label bears information 
concerning its vitamin, mineral and dietary properties.  Additionally, 21 U.S.C. § 343(j) 
recognizes as a type of food, product intended for “special dietary uses” based on its content.  
Section 403(j) provides for the issuance of mandatory label regulations. 
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that did not provide “taste, aroma or nutritional value” in a supplement form could 
not be sold as a food product and may have been subject to regulation as a drug.124 
In an attempt to provide a broad, expansive definition of dietary supplement (and 
ideally the integration of such products into the marketplace), The Dietary Health 
and Supplement Act of 1994 provides in part, that a dietary supplement means: 
a product (other than tobacco) intended to supplement the diet that bears 
or contains one or more of the following dietary ingredients: a vitamin; 
. . . a mineral; . . . an herb or other botanical; . . . an amino acid; . . . a 
dietary substance for use by man to supplement the diet by increasing 
total dietary intake; or . . . a concentrate, metabolite, constituent, extract, 
or combination . . . [of any ingredient previously described].125 
The Act further expands the definition of dietary supplement to include:  product 
which is intended for ingestion in “pill, capsule, tablet or liquid” form; is not meant 
to be a conventional food or singular meal or diet item; is labeled “dietary 
supplement” and may be approved as new drugs, certified as antibiotics or licensed 
as biologics, that were previously marketed as food or dietary supplements.126  It 
would appear that these definitions provided by the DSHEA are for broad 
application to a variety of products, regardless of their nutritional value. 
Despite the expanded definition, regulatory ambiguities remain.127  For instance, 
does the statutorily required ‘ingestion’ necessarily mean that the ingredients 
“supplement the diet” or “increase total dietary intake”?128  In the discussion at hand, 
to determine whether androstenedione, a naturally occurring steroid hormone and 
precursor to testosterone, come within the scope of the DSHEA dietary supplement 
definition, one could ask: (1) is andro a dietary substance, (2) is andro used to 
supplement the diet, and (3) does andro increase the total dietary intake?  The answer 
to these is not readily resolved, given the regulatory guidelines at hand. 
2.  Product Safety 
Prior to the DSHEA, the FDA had successfully argued that substances added to 
dietary supplements were like substances added to any other food product, and if 
such substances were generally not recognized as safe (GRAS), as supported by 
scientific documentation, they would be subject to regulation as “food additives.”129  
                                                                
124Nutrilab, Inc. v. Schweiker, 713 F.2d 335 (7th Cir. 1983).  Supporting the position that 
substances derived from food, but lacking food-type qualities could be classified as “drugs”, 
and not “foods” under the FDCA.  For purposes of the FDCA, “starch blockers” which 
“block” the human body’s digestion of starch as an aid in weight control, constituted a “drug” 
based on their function, despite having been derived from raw kidney beans. 
125Pub. L. No. 103-417, § 3(a), 108 Stat. at 4327 (codified at 21 U.S.C. 321(ff) 
(Supp.1996)). 
126Id. 
127Robert G. Pinco & Paul D. Rubin, Ambiguities of the Dietary Supplement Health and 
Education Act of 1994, 51 FOOD & DRUG L.J. 383, 384 (1996). 
128Id. 
12921 U.S.C. § 321(s)(6) (new section 201(ff)(2) of the FDCA). 
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This was a much welcome change since, like the regulatory gauntlet set forth for 
drugs, the additive clearance process was formidable.130 
As a result, supplement ingredients were now more free from the risk that they 
might be subject to the costly and far reaching allegations of “unapproved food 
additive” status, with which the burden lay on the processor to demonstrate that the 
product was generally recognized as safe.131  With safety in mind, the DSHEA did 
replace the additive provisions with added safety requirements for new dietary 
ingredients, e.g. those that “[were] not marketed in the United States before October 
15, 1994.”132  A product introduced after that date will be deemed unadulterated only 
if there is a “history of use or other evidence of safety establishing that the dietary 
ingredient when used under the conditions recommended or suggested in the labeling 
. . . will reasonably be expected to be safe.”133 
3.  Manufacturer Claims and Nutritional Support 
Section 6 of DSHEA explicitly authorizes dietary supplement labeling to contain 
four types of statements of nutritional support, including nutritional deficiency; 
structure/function (effect); structure/function (maintenance); and general well-
being.134 
In order to assert one of the above statements, a manufacturer must substantiate 
that the statement(s) are truthful and not misleading, and the product label must bear 
the statement “This statement has not been evaluated by the Food and Drug 
Administration.  This product is not intended to diagnose, treat, cure or prevent any 
disease.”135  As a practical matter, the DSHEA is not especially clear as to how much 
data is sufficient to legitimately substantiate such a statement.  The level of support 
does not have to rise to the level of the FDA requirement for new drugs (two 
                                                                
130Pinco & Rubin, supra note 127, at 385. 
131United States v. Two Plastic Drums . . . Black Current Oil, 984 F.2d 814 (7th Cir. 1993) 
(ruling that black currant oil in a gelatin capsule was not subject to regulation as a food 
additive, and that the FDA’s allegations of food additive status constituted an “Alice-in 
Wonderland approach…to make an end-run around the statutory scheme and shift to the 
processors the burden of proving the safety of a substance in all circumstances”).  Id. at 819. 
13221 U.S.C. § 350b(c) (new section 413(c) of the FDCA). 
133Id. at § 350b(a)(2) (new section 413(a) of the FDCA).   
134Id. at § 343(r)(6)(A).  Supplement label statements include: 
a statement that claims a benefit related to a classical nutrient 
deficiency disease and discloses the prevalence of such disease in the 
United States (a “nutrient deficiency” statement); 
a statement that describes the role of the nutrient or dietary ingredient 
intended to affect the structure or function in humans (a 
“structure/function” statement); 
a statement that characterizes the documented mechanism by which a 
nutrient or dietary ingredient acts to maintain such structure or function 
(also a “structure/function” statement); or 
a statement that describes general well-being from consumption of a 
nutrient or dietary ingredient (a “general well-being” statement). 
135Id. at § 343(r)(6)(B)-(C). 
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controlled clinical studies), though perhaps the standard should echo the Federal 
Trade Commission’s measure of “competent and reliable scientific evidence.”136   
As evidenced by many of the dietary supplements legally available on the market 
today, general recognition of safety and efficacy is not mandated by the DSHEA, nor 
is it required as a condition of legal sale. 
4.  Labeling 
Products should provide the information necessary for consumers to make 
informed decisions as to whether to use a product or not.137  Regulatory schemes for 
food, drugs and dietary supplements all require clear listings of product content, 
ingredients, descriptions and quantities.138 
As product labeling is an all-important conduit for consumer information, it is 
critical that information and warnings concerning a product’s potential danger be 
made available.  While most foods are not perilous even when consumed in large 
doses, it is not implausible to think that some consumers might attempt to get “faster 
results” by exceeding recommended dosages. 
Accordingly, dietary supplements and sports products in particular should strive 
to present labels that clearly establish recommended dosages and post warnings with 
regard to dangerous side effects from overexposure.139 Because the drug regulatory 
scheme is the only one that mandates this degree of information, dietary supplement 
manufacturers may wish to at least consider such disclosure with regard to labels. 
III.  REAL-LIFE APPLICATION AND RELATED ISSUES 
A.  The DSHEA in Action 
Dietary supplements, such as andro are not drugs but are instead are presumed by 
law to be foods.140  Because the FDA does not pre-approve foods or food label 
claims, manufacturers are simply required to provide assurance that their products 
and claims comport with the published regulatory requirements.141  Though the 
DSHEA legislation forbids companies from implying that a product has healing or 
preventative qualities with regard to a disease, a manufacturer can assert that the 
same product keeps a particular organ “functioning normally.”142  
Companies are supposed to submit such claims to the FDA, as well as safety data 
on any ingredients introduced after 1994.143  In the event that there is not sufficient 
                                                                
136Greenberg, supra note 19, at 5. 
137Congress found a growing need for the “dissemination of information linking nutrition 
and long-term good health.”  Dietary Supplement Health and Education Act of 1994, Pub. L. 
No. 103-417, § 2(7), 108 Stat. 4325, 4326 (1994). 
138See Food Labeling; Requirements for Nutrient Content Claims, Health Claims and 
Statements of Nutrient Support for Dietary Supplements, 60 Fed. Reg. 67,176 (1995). 
139See Fish, supra note 117, at E16. 
140Greenberg, supra note 19, at 5. 
141Id. 
142See Pub. L. No. 103-417, 108 Stat. at 4328. 
143Greenberg, supra note 19, at 5. 
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safety data, a manufacturer can be told to stop marketing the product and may be 
required to provide a disclaimer stipulating that their product claims have yet to 
undergo FDA evaluation.144  Such advertising issues fall under the dominion of the 
Federal Trade Commission (FTC), which has also issued its own guidance 
documents.145  
In the event that such regulatory requirements are violated, both the FTC and the 
FDA are empowered to request relevant data from a manufacturer and issue an order 
to cease production where necessary.146  In practice, enforcement is scant.  Despite 
these requirements, a marketer need not worry too much about product disclaimers, 
submitting required information to the FDA or gathering data in the event that the 
FTC comes calling.  In fact, the odds of being found in violation and actually 
disciplined are quite slim. 
Today, there are more than 20,000 dietary supplements on the market in the 
United States, part of a $15 billion industry, whose estimated annual growth rate 
exceeds twenty percent.147 In a match up tantamount to that of David and Goliath,148 
the Food and Drug Administration has only five employees dedicated to the handling 
of tens of thousands of dietary supplements.149 Not surprisingly, the supplement 
industry continues to grow at a pace that remains far beyond the regulatory span of 
control.   
Given the volume of products entering the marketplace at such a rapid pace, it is 
not surprising that there is very little accompanying documentation regarding their 
efficacy and the health consequences of long-term use. The DSHEA contains a 
companion section, which provides that a supplement will be deemed adulterated if it 
contains “a new dietary ingredient for which there is inadequate information to 
provide reasonable assurance that such ingredient does not present a significant or 
unreasonable risk of illness or injury.”  Despite these provisions, unsubstantiated 
products abound in the marketplace.150  
Of course, “legal” does not necessarily mean “safe,” especially since the 
DSHEA’s function is to effectively limit regulation of dietary supplements.  It is 
imprudent to think that products such as andro are safe simply because there is no 
legally mandated data to demonstrate otherwise.  For now, these potentially perilous 
products are classified as supplements and remain free to enter the marketplace sans 
evidence of safety or efficacy.  
                                                                
144Id. 
145Id. 
146Rochelle Sharpe, Staking Claims: One Effect of a Law on Diet Supplements is Leaner 
Regulation—With a Web Site, Smart Ads and Supplier, One Man Scores on a ‘Stud Pill’, 
WALL STREET JOURNAL, Jan. 27, 1999 at A1.  (A former securities broker turned andro 
distributor established a thriving mail order supplement business by marketing the product as a 
“stud pill” over the internet and through press releases in financial news wires.). 
147Id. 
1481 Samuel 17:4-51. Referencing Goliath, the giant Philistine warrior who was slain by 
David with a stone and a sling. 
149Sharpe, supra note 146, at A1. 
15021 U.S.C. § 342(f)(1)(B) (new section 402(f)(1)(B)of the FDCA). 
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Consumers must remain cognizant of the fact that a negative safety and/or 
efficacy determination may make it more difficult for a company to substantiate 
certain product statements, but it does not necessarily preclude the use of such 
statement, let alone make the product illegal.  
Until andro and other untested substances are subject to more stringent regulatory 
controls such as pre-market approval or testing, potential users (and abusers) must be 
forewarned about the potential health risks associated with the product.  Similarly, it 
would be prudent for sports authorities to regard the “unknown” with the same 
gravity, when determining which performance enhancing substances (if any) should 
be allowed by the respective organizing bodies. 
B.  Forms and Types of Product 
1.  The Supplement Debate 
As examined in the previous section, the heart of this question is perhaps 
shrouded by the cloudy regulatory scheme that grew out of the passage of the 
Dietary Supplemental Health Act of 1994 (DSHEA).  By definition, dietary 
supplements are not drugs and are presumed by law to be foods; accordingly, the 
FDA does not pre-approve food or food label claims.151 
In keeping with their classification as a “food” rather a drug, andro and creatine 
are no longer the exclusive dominion of hardcore body building stores and 
underground mail order—instead, as unregulated supplements, they can be found on 
your neighborhood grocer or pharmacists’ shelf. Although many of the product 
claims are unsubstantiated, consumers are turning in droves to dietary supplements, 
such as ginseng for an energy boost, St. John’s Wort- to chase the blues away and 
ginkgo biloba to better the memory.152 
Athletes are big users and help spur the popularity of supplements that purport to 
boost athletic performance.  In the quest for the ultimate mental or physical edge, 
Americans are spending billions on pills, powders, gels, energy bars and sports 
drinks.153  The Nutrition Business Journal is forecasting a six to ten percent increase 
in sports product sales this year,154 though little is really known, or required by law, 
about their efficacy and physiological consequences. 
Some healthcare professionals feel that the physiological effects of supplements 
may vary with individual body composition and metabolism; as a result they are 
concerned with an industry short on research and regulation.155  A desire for short-
                                                                
151Greenberg, supra note 19, at 5. 
152Higgins, supra note 72, at 61. 
153See GNCI supra note 118. 
154Deborah Funk, Powders, Pills, Energy Boosters: Are They Safe to Take? Experts 
Debate Risks Involved with Supplements, FLA.TODAY, Dec. 29, 1998 at 5D. 
155Id.  In September, the American College of Sports Medicine asked the FDA to take 
another look at supplements, arguing that some should be classified as drugs.  Similarly, the 
American Dietetic Association believes that dietary supplements should be regulated like 
foods and that all related health claims should have a significant scientific basis.  See also, 
Russ Colchamiro, Supplement Controversy Shadows McGwire’s Home Run Record, 
AM.DRUGGIST, Oct.1, 1998 (citing a sampling of pharmacists who generally agreed that 
supplements should be regulated, tested and approved; either by the FDA or a similar agency). 
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term athletic performance gains and a lack of forethought as to the long-term effects 
may lead some supplement users to exceed recommended doses in hopes of 
achieving faster, more dramatic effects.156   
Athletes like Mark McGwire helped to fuel such desires, while 
contemporaneously doing wonders for supplement sales.  Night after night, millions 
of Americans tuned into watch this stellar physical specimen, and supplement 
devotee, chase a baseball dream. 
2.  The Androstenedione Example   
While andro has been around for years, it burst back into the media spotlight in 
August 1998 when an Associated Press reporter spotted a bottle of the legal but 
controversial steroid precursor in McGwire’s locker.157  Ignoring his critics, the soon-
to-be-crowned home run champion explained that he used the product to protect 
himself from muscle tears and to enable him to recover more rapidly from 
workouts.158   
From a performance perspective, the body breaks andro down into testosterone; 
the resultant increase in blood testosterone levels may result in greater energy, 
enhanced recovery and muscle growth from exercise.159  On the flip side, andro’s 
steroid qualities place it in the class of potentially hazardous, performance enhancing 
anabolic steroids which have been linked to coronary disease, cancer, liver 
dysfunction and severe mood disorders, including fits of steroid-induced rage.160 
Andro is not a new supplement and may have been an active component in the 
old East German “doping system” established for its athletes.161  Documents 
discovered after the unification of East and West Germany showed evidence of 
extensive experiments with androstenedione.162  East German scientists developed a 
mandatory nasal steroid application for all athletes competing in the 1988 Seoul 
Olympics.163 
                                                                
156Funk, supra note 155. 
157Rick Reilly, Hey Mac, Do What Comes Naturally, CNN-SI NEWSWIRE, Mar. 2, 1999 
(visited April 5, 1999)<http://www.cnnsi.com/inside_game>. 
158Okrent, supra note 4, at 138. 
159Ross Newhan, Baseball’s Great Chase Turns Into Great Debate, L.A. TIMES, Aug. 25, 
1998 at C1. With regard to the increase in testosterone levels resulting from the consumption 
of andro, data is extremely scarce.  Accordingly to a German Patent application for 
androstenedione, 50 mg. given orally to men raised blood testosterone levels from 140% to 
183%, and at 100 mg. raised levels from 211% to 237%.  These increases should begin to 
occur about fifteen minutes after consumption, and remain elevated for about three hours. 
160Id. 
161Scott M. Reid, An Issue of Substance, ORANGE COUNTY REGISTER, Aug. 22, 1998, at 
D1. 
162Id.  See Also, U.S. Seeks Redress for 1976 Doping in the Olympics, N.Y. TIMES, Oct. 25, 
1998 at 33,35.  Detailing the international protest regarding Olympic medals won by East 
Germany, currently under protest because of increasing evidence of doping by the GDR 
athletes. 
163Reid, supra note 161 at D1. 
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Indeed, andro’s classification as a dietary supplement makes it legal, readily 
available and well within the rules of baseball.164 The “drug” controversy arises from 
the fact that androstenedione is a hormonal-related testosterone precursor which 
carries all the components of an anabolic steroid.165 Testosterone, the male hormone 
which andro converts into after ingestion, is a highly controlled substance requiring a 
triplicate prescription before dispensation.166  
Domestically, very little is known about andro and as a result of the health and 
ethical issues posed by McGwire’s revelation.  Major League Baseball has vowed to 
craft a policy on this and other performance enhancing substances.167  The league 
commissioned two Harvard researchers to study the effects of andro in hopes of 
making a decision as to whether the league should ban the substance, discourage its 
use or allow it to be taken unchecked.168 
Similar questions have been raised by members of the medical community, 
including the Endocrine Society, the world’s oldest and largest organization devoted 
to research on hormones, which announced its position that not enough is known 
about andro to declare the substance safe and/or effective.169 
The National Toxicology Program Interagency Committee for Chemical 
Evaluation and Coordination (hereinafter ICCEC) has nominated andro for testing.170  
This recommendation was based on the media frenzy that followed the disclosure of 
McGwire’s use of andro, the product’s steroid nature, a lack of clinical data and 
potential side effects.  The andro issue has heightened awareness of the fact that the 
FDA lacks the necessary authority to appropriately regulate dietary supplements.171 
At the consumer level, one major retailer saw fit to discontinue the sale of andro 
nationwide, based on the lack of suitable research demonstrating the safety of the 
product at various intake levels and concern about the potential impact of product 
                                                                
164Okrent, supra note 4, at 138. 
165Newhan, supra note 159. 
166Id.  Technically, the origin of all steroid hormones is the cholesterol molecule. 
Cholesterol is metabolized into a steroid hormone called pregnenolone, and in turn is 
eventually converted into DHEA (steroid hormone), which then converts to androstenedione 
(andro).  Andro then converts into testosterone (the male steroid hormone), as well as estrone, 
which is an estrogen.  This last conversion is critical, as androstenedione is chemically, only 
one enzymatic step away from testosterone, a strictly controlled drug. 
167Steve Wilstein, Heavy Hitters Weigh in on Andro Debate, CHI.  TRIB., Jan. 3, 1999 at 
D1. 
168Id. According to representatives from Champion Nutrilab, Inc., the company that 
supplies McGwire with his supplements and has endorsement deals with many other 
professional players, at least 100 ball players in the major and minor leagues use andro 
regularly. 
169The Endocrine Society is a 9,000 member group of doctors and scientists dedicated to 
the study of hormones.  The Endocrine Society (visited July 14, 1999)<http://www.endo-
society.org/index.htm> 4350 East West Hwy.,Suite 500, Bethesda, MD 20814-4410. 
Tel:(301)941-0200, Fax:(301)941-0259.  E-mail: endostaff@endo-society.org. 
170Department of Health and Human Services, 63 Fed. Reg. 241, 245 (1998) (See 4 THE 
TAN SHEET,FDA REP., Jan. 4, 1999).  
171Id. 
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abuse.172  Whether andro is a benign muscle enhancer or a dormant hazard lying in 
wait remains to be determined.  It is, however, a risk that General Nutrition Stores 
(GNC) is not willing to take in any of its 3700 stores across the country. 
Any definitive correlation found between andro usage and increased levels of 
testosterone may be legitimate cause for concern because harmful side effects can 
take years to manifest.  Unlike most drugs, the adverse impact of steroids usually do 
not appear until long after the time of use.173  It is this reality that has led to the 
banning of andro from the Olympics, the NFL and the NCAA, all of which have 
classified the substance as an anabolic steroid 
Beyond the obvious chemical implications, one argument for andro to be 
classified as a drug, and treated accordingly in sports, is that use of the product will 
generate a positive result for testosterone on a steroid urinalysis test.174  Even if andro 
has natural origins, it breaks down into a compound that mirrors illegal, anabolic 
steroids. 
How can a level playing field ever be established where it is impossible to 
differentiate between athletes using legal and illegal performance aids?  For now, 
that all depends on who you play for—contrast Olympic shot put champion Randy 
Barnes’ lifetime ban from track and field by the International Amateur Athletic 
Federation for using andro, 175 with McGwire’s basking in the glory of legally 
crushing Roger Maris’ single season home run record.  The sadly divergent 
directions in which Barnes and McGwire find their careers heading is reflective of 
the wildly inconsistent approach within sport, to the use of performance-enhancing 
substances.176 
                                                                
172Rick Morrissey & Bruce Japsen, McGwire’s Spiked Swing Raises Health Questions, 
CHI. TRIB., Aug. 26, 1998. 
173Id. 
174Internet advertisement for “Andro-forte 100,” describes andro as the “single best food” 
available to support the body’s natural production of testosterone.  The product description 
also includes a warning which states that “product usage may generate positive results on a 
steroid urinalysis test. <http://www.undergroundsports.com/andro-forte.htm> (visited April 5, 
1999). 
175See Maher, infra note 179. 
176MLB Unlikely to Rule on Andro in ’99, AP NEWSWIRE, Feb. 26,1999.  The number two 
official of the Major League Baseball player’s association, Gene Orza “assumes” andro is 
safe, “because the United States government chooses not to regulate it.”  The concerns of 
steroid experts, who warn of serious health consequences for teen-agers who take the 
supplement to emulate McGwire will not factor into the union’s decision according to Orza.  
The union will consider a ban on andro only if it is found to give some players a competitive 
advantage over others.  Unlike the Olympics, NFL and tennis tour, baseball does not have a 
random testing program for illegal substances.  Compare,  NBA Players Told to Keep Off the 
Grass, PLAIN DEALER, July 9, 1999 at D2.  NBA player’s union advising player 
representatives that they will be tested for marijuana when training camps open in October.  
NBA players who test positive at training camp must undergo a mandatory counseling 
program.  A second positive test brings a $15,000.00 fine, and any third or subsequent positive 
test results in a five-game suspension.  Contrast this with baseball’s Orza on why the baseball 
player’s association objects to testing, “[w]e don’t believe that in America people are required 
to give evidence of wrongdoing to their employers . . . testing for illegal drugs and testing for 
performance-enhancing drugs are quite different.” 
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C.  Sports and Drugs, Drugs in Sport: Winning at What Cost 
Since the time of the early Greeks, athletes have been looking for ways to get an 
edge on the competition.177  In ancient times, as today, performance-enhancing 
supplements have been a major strategy.178  Regrettably, as evidenced by 1998, 
during which an unprecedented number of drug-related incidents occurred in sports, 
athletes appear to be on the edge: doping and drugging to win at all costs.179   
From badminton to baseball, soccer to swimming and the ubiquitous problems in 
track and cycling, perhaps the saddest symbol of the times were the once proud 
Olympic rings.  When the andro issue first emerged, Major League Baseball sought 
to consult with the venerable International Olympic Committee (IOC) to develop a 
strategy for managing and regulating performance enhancing substances amongst the 
league’s players.  In turn, the IOC envisioned developing its own anti-doping agency 
during a three day summit on drugs and sports held earlier in the year. 
Following three days of debate, a global answer to the doping plague was no 
more clear as the beleaguered Olympic committee received a resounding “no” vote 
of confidence from the IOC membership, left without a new agency, and instead had 
to settle for a “committee” that would continue to look at anti-doping strategies.180  
To add insult to the indignities already brought forth by cheating on the playing 
fields, the world sat back and watched a soap opera-like tale of back room bribery 
and scandal unfold relative to the Olympic Site Selection process.181   
It is bitterly ironic that the recent desperate measures employed by administrators 
and athletes alike are representative of a society on the proverbial edge—blinded by 
a desire to get ahead and perhaps willing, in any way, shape or form, to pay the 
requisite price.  Be it an indictment or jail time for influence peddling, or perhaps a 
lifelong suspension for ingesting the “wrong” supplement—some athletes seem 
willing to risk even greater unknowns by experimenting with wholly untested 
substances, all in the name of short-term gain. 
IV.  TOWARDS A NEW ALTERNATIVE  
A.  Re-defining the Focus 
Rather than continuing to operate under the presumption that the administrative 
tug-of-war between Congress and the FDA will go on in perpetuity, consideration 
                                                                
177Instances of athletes using performance-enhancing substances dates back over 2000 
years, when Charmis, the winner of the 200m sprint in the Olympic Games of 668 BC 
prepared for the event by ingesting a special diet of dried fig leaves. 
<http://www.ausport.gov.au/drug.html.>(visited July 14,1999). 
178Id. 
179John Maher, The Year on Drugs, AUSTIN-AMERICAN STATESMAN, Dec. 29, 1998 at C4. 
Worldwide, more than 150 incidents were documented worldwide in which illegal drugs and 
sports were an issue.  In addition to sports like cycling, track and baseball where such 
infractions are regrettably familiar, violators were found in unexpected places like snooker, 
badminton and snowboarding. 
180Paul L. Montgomery, IOC Adopts a Watered Down Drug Declaration, N.Y. TIMES, 
Feb. 5, 1999 at C1. 
181Id. 
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should be given to the development of methods to protect consumers within the 
reduced scope of regulatory powers. 
The existing legal system already provides an indirect way for consumers to use 
supplements for disease prevention and treatment purposes by the very availability of 
products labeled dietary supplements.  The ambiguously constructed DSHEA seems 
to protect the accessibility of dietary supplements, even though consumers may, on 
their own initiative, procure these products for drug purposes.  Either intentionally or 
by default, the DSHEA gives consumers the choice and ability to use supplements to 
treat disease.182  This type of use, referred to as “off label” in the health care industry, 
is an informal characterization of an unregulated substance or FDA approved drug 
for a purpose other than that which may have originally been intended.183 
Use of drugs on an off label basis, such as high blood pressure medication to 
combat male pattern baldness (Rogaine), is somewhat analogous to consumer use 
of dietary supplements for unapproved purposes.  Neither these consumers, nor the 
physicians who prescribe ‘extra-label’ use as part of the practice of medicine, are 
operating in contravention of the law.184 
Pre-market approval, restriction of nutritional claims and enhanced labeling 
requirements are among the techniques that the FDA might employ in the regulation 
of products such as andro.  Because such products meet the statutory definition of 
dietary supplement, they escape FDA scrutiny as drugs.185 
While the DSHEA effectively dismantled the FDA’s authority to adequately 
police dietary supplements, more appropriate regulation might be possible if 
Congress encourages pre-market approval.  Supplement manufacturers should have 
an enforceable obligation to substantiate, at the very least, a product’s safety.  In 
turn, the FDA should be allowed to determine whether manufacturers have met this 
implied legal obligation and the accompanying claims set forth. 
                                                                
182See Legal Status of Approved Labeling for Prescription Drugs; Prescribing for Uses 
Unapproved by the Food and Drug Administration, 37 FED. REG. 16503, 16503-04 (1972); 
Richard A. Merrill, The Architecture of Government Regulation of Medical Products, 82 VA. 
L. REV. 1753 (1996) (for a discussion of how, under the 1997 drug reform law, for the first 
time, a manufacturer can refer to scientific studies for off label (use other than originally 
intended) uses under certain conditions). 
183Merrill, supra note 182. 
184Id. 
185The term “dietary supplement”— 
(1) means a product (other than tobacco) intended to supplement the diet that bears or 
contains one or more of the following dietary ingredients: 
(A) a vitamin; 
(B) a mineral; 
(C) an herb or other botanical; 
(D) an amino acid; [or] 
(E) a dietary substance for use by man to supplement the diet by increasing the total 
dietary intake. . . . Food, Drug and Cosmetics Act (FDCA), § 201(ff)(1)(A)-(E), 21 
U.S.C. § 321(ff)(1)(A)-(E)(1994). 
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V.  CONCLUSION 
Like the Babe, who set the big league bar with sixty home runs back in 1927, and 
Roger Maris who raised it by one in 1961, Mark McGwire’s magical feat will 
undoubtedly beckon like a ballpark siren’s call to the sluggers of tomorrow.  For now 
though, McGwire deserves to bask unashamedly in the glory of his seventy run 
crown and a newly minted baseball record. 
Unlike the scores of other public figures whose indignities we had to stomach 
during the past year, Big Mac did not lie and he did not cheat—he simply played by 
the rules of his game.  And ideally, long before we ordain our next home run hero, 
the rules of the game will change for the better.  After all, just because something is 
legal does not mean it is safe, or for that matter, effective. The mere absence of 
statistically demonstrable risk seems like a rather foolish basis for endorsement. 
The current state of affairs surrounding the multi-million dollar sports product 
industry is indicative of the need for a look at reforming the FDA’s attempt to 
regulate the dietary supplement industry.  Doing so would still comport with the 
legislature’s intent to allow for increased flexibility in the regulation of dietary 
supplements as opposed to drugs.  The ultimate goal of enhancing consumer safety 
could be actualized by the FDA’s being given the enhanced ability to distinguish 
between those dietary supplements that do require strict regulation and the many that 
do not. 
In addition to preserving the precious sanctity of athletic competition, we should 
strive to shield the public safe from potential harm brought on by untested products.  
In the long term, the FDA should have the authority to regulate supplements to a 
reasonable level of scientific honesty and establish a brighter line between legitimate 
nutritional additives and performance enhancing drugs. 
The possible side effects produced by these substances may not manifest until far 
into the future and accordingly; today’s explosive gain in power and strength may 
come with dubious strings attached.  Until it can be substantiated how a product 
should be classified; how well it works, if at all; and above all, if it’s safe, we can 
hardly afford to sell our regulatory souls to an indifferent devil.  
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